Earnings estimate | Current qtr. (Jun 2024) | Next qtr. (Sep 2024) | Current year (2024) | Next year (2025) |
---|---|---|---|---|
No. of analysts | 1 | 1 | 2 | 2 |
Avg. Estimate | 0.38 | 0.36 | 2 | 2.64 |
Low estimate | 0.38 | 0.36 | 1.44 | 2.06 |
High estimate | 0.38 | 0.36 | 2.56 | 3.23 |
Year ago EPS | 0.35 | 0.2 | 0.55 | 2 |
Revenue estimate | Current qtr. (Jun 2024) | Next qtr. (Sep 2024) | Current year (2024) | Next year (2025) |
---|---|---|---|---|
No. of analysts | 2 | 2 | 3 | 3 |
Avg. Estimate | 7.68B | 7.53B | 31.39B | 35.24B |
Low estimate | 7.67B | 7.16B | 30.16B | 32.56B |
High estimate | 7.7B | 7.9B | 32.31B | 37.3B |
Year ago sales | 6.35B | N/A | 27.02B | 31.39B |
Sales growth (year/est) | 21.00% | N/A | 16.20% | 12.20% |
Earnings history | 29/06/2023 | 29/09/2023 | 30/12/2023 | 30/03/2024 |
---|---|---|---|---|
Est. EPS | 0.59 | 0.84 | 2.06 | -0.32 |
Actual EPS | 0.35 | 0.2 | 0.54 | -0.09 |
Difference | -0.24 | -0.64 | -1.52 | 0.23 |
Surprise % | -40.70% | -76.20% | -73.80% | 71.90% |
EPS trend | Current qtr. (Jun 2024) | Next qtr. (Sep 2024) | Current year (2024) | Next year (2025) |
---|---|---|---|---|
Current estimate | 0.38 | 0.36 | 2 | 2.64 |
7 days ago | 0.38 | 0.36 | 1.68 | 4.01 |
30 days ago | 0.38 | 0.36 | 2.67 | 4.06 |
60 days ago | 0 | 0 | 3.02 | 4.35 |
90 days ago | 0 | 0 | 2.99 | 4.32 |
EPS revisions | Current qtr. (Jun 2024) | Next qtr. (Sep 2024) | Current year (2024) | Next year (2025) |
---|---|---|---|---|
Up last 7 days | N/A | N/A | 1 | 1 |
Up last 30 days | N/A | N/A | 1 | 1 |
Down last 7 days | N/A | N/A | N/A | N/A |
Down last 30 days | N/A | N/A | N/A | N/A |
Growth estimates | EMBR3.SA | Industry | Sector(s) | S&P 500 |
---|---|---|---|---|
Current qtr. | 8.60% | N/A | N/A | N/A |
Next qtr. | 80.00% | N/A | N/A | N/A |
Current year | 263.60% | N/A | N/A | N/A |
Next year | 32.00% | N/A | N/A | N/A |
Next 5 years (per annum) | N/A | N/A | N/A | N/A |
Past 5 years (per annum) | -2.59% | N/A | N/A | N/A |